Viking Therapeutics VKTX Total debt

Total debt at other companies

Eli LillyLLY

$54.91B+37.6%

PfizerPFE

$64.43B+4.9%

AmgenAMGN

$57.3B+2.0%

Gyre Therapeutics, Inc.GYRE

$3.42M+145%

Madrigal Pharmaceuticals, Inc.MDGL

$377.85M+179%

VAN

Vivani MedicalVANI

$18.28M-3.5%

FAQ

What is Viking Therapeutics's total debt?

Viking Therapeutics (VKTX) reported total debt of $137K in Q4 2025.

How has Viking Therapeutics's total debt changed year-over-year?

Viking Therapeutics's total debt decreased by 87.8% year-over-year, from $1.12M to $137K.

What is the long-term trend for Viking Therapeutics's total debt?

Over 5 years (2020 to 2025), Viking Therapeutics's total debt has grown at a -17.5% compound annual growth rate (CAGR), from $359K to $137K.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.